"Miracles are like pimples, because once you start looking for them, you find more than you ever dreamed you'd see." - Lemony Snicket, The Lump of Coal
Today we take a look a developmental biotech concern that is deep in "Busted IPO" territory. However, if things fall right for the company, substantial capital appreciation could lie ahead. A full analysis is presented in the paragraphs below.
Company Overview
Ovid Therapeutics, Inc. (OVID) is a New York City-based biopharmaceutical concern focused on the development of therapies for the treatment of rare neurological disorders.